Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.

doi:10.1016/j.idc.2020.06.001

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Drug-Resistant Tuberculosis: A Glance at Progress and Global Challenges.

Infectious disease clinics of North America - 1 Dec 2020

Dousa Khalid M, Kurz Sebastian G, Bark Charles M, Bonomo Robert A, Furin Jennifer J

Abstract excerpt

Multidrug-resistant Mycobacterium tuberculosis remains a major public health threat; its management poses a significant economic burden. Treatment requires a programmatic approach with access to laboratory services, second-line medications, and adequate clinical resources. In recent years, we have seen rapid developments in diagnostic techniques with whole genome sequencing-based drug susceptibility prediction...

Topics

Anti-Bacterial Agents
Antitubercular Agents
Early Diagnosis
Genome, Bacterial
Humans
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis
Tuberculosis, Multidrug-Resistant
Whole Genome Sequencing

Source

Open in PubMed

Identifiers

PMID: 33011048
DOI: 10.1016/j.idc.2020.06.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics